Navigation Links
Companion Diagnostics in Personalized Medicine and Cancer Therapy
Date:8/6/2014

ends. Moreover, this analysis profiles the leading companies that are developing and manufacturing companion diagnostics solutions. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market share data are also included.

TABLE OF CONTENTS
1. Overview 9
1.1 Statement of Report 9
1.2 About This Report 9
1.3 Scope of the Report 10
1.4 Objectives 11
1.5 Methodology 12
1.6 Executive Summary 13

2. Companion Diagnostics: Trends and Overview 19
2.1 Stakeholders in Companion Diagnostics 19
2.2 Development of Stakeholders' Business Models for Companion Diagnostics for Personalized
Medicine 21
2.2.1 Pharmaceutical Company Business Models for Developing Companion Diagnostics Products 21
2.2.2 Diagnostic Company Business Models for Developing Companion Diagnostics Products 22
2.2.3 Life Science Company Business Models for Developing Companion Diagnostics Products 22
2.2.4 Pharmacy Benefit Management Company Business Models for Developing Companion Diagnostics Products 23
2.3 Trends in Companion Diagnostic Deals 23
2.4 Market Size of Companion Diagnostics 24

2.5 Companion Diagnostics: Industry SWOT Analysis 31
2.6 Challenges for Companion Diagnostics Development 31
2.7 Timeline for Impact of Various Segments in Companion Diagnostics 33
2.8 Use of Proteomics to Develop Individualized Tests 35

3. Companion Diagnostics: Qualitative and Quantitative Market Analysis 38
3.1 Market Analysis of Molecular Diagnostics and Companion Diagnostics 38
3.2 Costs of Companion Diagnostics in Healthcare Expenditures 40
3.3 Molecular Diagnostic Market 41
3.4 Molecular Diagnostics Technology Platforms and Their Impact on Clinical Medicine 43
3.5 Snapshot of Companion Diagnostics Industry Str
'/>"/>

SOURCE ReportBuyer
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Ventana paves the way for companion diagnostic early phase clinical trials in China to advance patient care
2. QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients
3. Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment
4. Ventana announces HER2 companion diagnostic to identify breast cancer patients for Roches latest targeted medicines, Perjeta and Kadcyla
5. Ventana to partner with Incyte on the development of Companion Diagnostic tests
6. Kennel Cough is in Season all Year for our Canine Companions
7. Harrisvaccines, Inc. Secures Exclusive Rights From AlphaVax, Inc. to Develop RNA Particle Vaccines for All Diseases in Companion Animals
8. Ventana receives approval from Chinas FDA for first fully automated IHC companion diagnostic identifying ALK protein expression in lung cancer patients
9. Companion Diagnostics Market Report - Streamlining Drug Development and Advancing Personalized Medicine
10. Companion Diagnostics Market, 2012-2023
11. Companion 2 Hospital Driver for Powering SynCardia Total Artificial Heart Wins Silver at Medical Design Excellence Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015  ResMed (NYSE: RMD ) ... agreement to acquire Curative Medical, a privately-held ... breathing medical devices and accessories. ... leadership in sleep and respiratory medicine, will ... suffering from sleep-disordered breathing and ...
(Date:7/30/2015)... IRVINE, Calif. , July 30, 2015 /PRNewswire/ ... Novartis /Alcon executives have recently contacted the Company ... will begin as early as Monday, August 3, ... been quoted as saying that the coming electronic ... billions of dollars over the next several years.  ...
(Date:7/30/2015)... -- Amgen (NASDAQ: AMGN ) today announced financial ... results include: , Total revenues increased 4 ... $5,370 million, with 6 percent product sales growth ... ® (denosumab), Sensipar ® (cinacalcet), Kyprolis ... Unfavorable changes in foreign exchange rates impacted total ...
Breaking Medicine Technology:ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23
... 2011 BD (Becton, Dickinson and Company) ... technology company, announced today that it is donating $325,000 ... earthquake and tsunami in Japan. BD will distribute these ... AmeriCares, American Red Cross, Direct Relief International, Heart to ...
... March 15, 2011 New Image Global, Inc., ... recently joined forces with the disability advocacy group, ... donated artificial limbs to candidates disabled by amputation ... manufacturing facility in Santiago, Dominican Republic.) Under the ...
Cached Medicine Technology:BD Donates $325,000 for Japan Earthquake and Tsunami Relief Efforts 2
(Date:7/31/2015)... ... July 31, 2015 , ... Girl Scouts of Historic ... across Georgia through the Girl Scout "Be a Friend First" program. Representatives from Peach ... 30. , “Peach State Health Plan and our parent company, Centene Corporation, are ...
(Date:7/31/2015)... ... , ... Like nearly every other form of surgery, it shouldn't come as ... and less intrusive and painful. Leading these advances in the United States has ... stands as the only doctor in the United States who is qualified to practice, ...
(Date:7/31/2015)... ... 31, 2015 , ... Florida Hospital Tampa has started treating ... for targeted delivery of fluids to selected sites in the peripheral vascular system. ... with the device that provides direct, local delivery of chemotherapy to the pancreas. ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... proud to announce that their latest designer handbag line will be named for ... an Internet sensation as the first globally recognized model with Down syndrome, gracing ...
(Date:7/31/2015)... ... July 31, 2015 , ... According to WFLA on July ... heroin use and eventual overdoses. Thricefold deaths have held steady over the last “couple ... the Sarasota heroin epidemic, which was spurred by the crackdown of prescription painkillers. Many ...
Breaking Medicine News(10 mins):Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 4Health News:everMaya to Launch Madeline Stuart Handbag Line 2Health News:everMaya to Launch Madeline Stuart Handbag Line 3Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 2Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 3
... and other chemicals boost their odds of respiratory ... News) -- Frequent exposure to hospital cleaning products ... according to a U.S. study that included 3,650 ... The researchers found that nurses regularly exposed to ...
... 20 MPR ( Monthly Prescribing Reference ) is pleased to ... For over 25 years, physicians and other healthcare professionals ... our drug database for up-to-date, concise drug information at the point-of-care.The ... will also offer a number of added features and functionality: , ...
... Jan. 20 Northern Trust announced today,that it ... North Shore-LIJ Health,System, the nation,s third largest not-for-profit ... custodian, benefit payment, plan accounting,and investment risk and ... invested funds. , "North ...
... IT pioneer doubles annual revenues, brings on hundreds of ... today announced 200 percent revenue growth in 2008. ... system, integrated delivery network (IDN) and health information exchange ... bookings and the addition of some 200 hospitals to ...
... to target only the tumor, researchers explain , , ... therapy that uses beads soaked with anti-cancer agents has ... studies. , Transarterial chemoembolization (TACE) attacks liver ... cancer-killing chemotherapeutic agents are delivered to the blood vessel ...
... /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, Inc. (Pink Sheets: RHGP) (,Renhuang, ... People,s Republic of China (,PRC,),today announced that it ... new,independent auditor, effective January 9, 2009. Moore ... was dismissed on the same,day. , ...
Cached Medicine News:Health News:Cleaning Products Up Nurses' Asthma Risk 2Health News:MPR Re-Launches its Up-to-Date Drug Reference Website 2Health News:Northern Trust Named Global Custodian to North Shore-LIJ Health System in New York 2Health News:Carefx Reports 200% Year-Over-Year Revenue Growth in 2008 as Demand Grows for Solutions Focused on Clinical Decision Making 2Health News:Carefx Reports 200% Year-Over-Year Revenue Growth in 2008 as Demand Grows for Solutions Focused on Clinical Decision Making 3Health News:Tiny Chemo Beads Boost Liver Cancer Outcomes 2Health News:Tiny Chemo Beads Boost Liver Cancer Outcomes 3Health News:Renhuang Pharmaceuticals, Inc. Engages New Independent Auditor 2
... VH series, it is a ... independent C-arms and image intensifiers, ... for Cardiovascular and Angiography. There ... the examinations for cerebral, cardiac, ...
This catheter is intended for ultrasound examination of coronary intravascular pathology ONLY. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
Rubidium Rb 82 Generator. ,The only generator-based Positron Emission Tomography agent reimbursed for the evaluation of coronary artery disease....
Kit for the Preparation of Technetium Tc 99m Teboroxime...
Medicine Products: